表紙
市場調査レポート

中国の遺伝子検査市場の見通し

China Genetic Testing Market Outlook to 2021

発行 GlobalData 商品コード 346055
出版日 ページ情報 英文 27 Pages
即納可能
価格
本日の銀行送金レート: 1USD=105.42円で換算しております。
Back to Top
中国の遺伝子検査市場の見通し China Genetic Testing Market Outlook to 2021
出版日: 2015年08月14日 ページ情報: 英文 27 Pages
概要

当レポートでは、中国の遺伝子検査市場について調査分析し、セグメント別の収益実績・予測、カテゴリー別の企業シェア・流通シェア、主要企業のプロファイルなど、体系的な情報を提供しています。

第1章 目次

第2章 イントロダクション

第3章 中国の遺伝子検査市場

  • 収益実績
  • 収益予測
  • 流通シェア:収益別
  • 企業シェア:収益別

第4章 中国の主要企業の概要:遺伝子検査市場

  • 企業概要
    • F. Hoffmann-La Roche Ltd.
    • Danaher Corporation
    • Abbott Laboratories
    • Siemens Healthcare
    • Hologic, Inc.
    • Transgenomic, Inc.
    • Bio-Rad Laboratories, Inc.
    • Qiagen N.V.

第5章 遺伝子検査市場パイプライン製品

第6章 財務取引情勢

  • パートナーシップ

第7章 付録

図表

目次
Product Code: GDMECC1244DB

GlobalData's new report, "China Genetic Testing Market Outlook to 2021", provides key market data on the China Genetic Testing market. The report provides value, in millions of US dollars within market segments - Acquired Gene or Chromosome Alterations, Inborn Gene or Chromosome Alterations and Other Genetic Tests.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Genetic Testing market includes Acquired Gene or Chromosome Alterations, Inborn Gene or Chromosome Alterations and Other Genetic Tests.
  • Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
  • 2014 company shares and distribution shares data for Genetic Testing market.
  • Global corporate-level profiles of key companies operating within the China Genetic Testing market.
  • Key players covered include F. Hoffmann-La Roche Ltd., Siemens Healthcare, Danaher Corporation, Abbott Laboratories, Hologic, Inc., Cepheid, Bio-Rad Laboratories, Inc., Qiagen N.V., Transgenomic, Inc. and PerkinElmer, Inc.

Reasons to buy

  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. What Is This Report About?
  • 2.2. Genetic Testing Market Segmentation
  • 2.3. Definitions of Markets Covered in the Report

3. Genetic Testing Market, China

  • 3.1. Genetic Testing Market, China, Revenue ($m), 2007-2014
  • 3.2. Genetic Testing Market, China, Revenue ($m), 2014-2021
  • 3.3. Genetic Testing Market, China, Distribution Share by Revenue ($m), 2013-2014
  • 3.4. Genetic Testing Market, China, Company Share by Revenue ($m), 2014

4. Overview of Key Companies in China, Genetic Testing Market

  • 4.1. F. Hoffmann-La Roche Ltd.
    • 4.1.1. Company Overview
  • 4.2. Danaher Corporation
    • 4.2.1. Company Overview
  • 4.3. Abbott Laboratories
    • 4.3.1. Company Overview
  • 4.4. Siemens Healthcare
    • 4.4.1. Company Overview
  • 4.5. Hologic, Inc.
    • 4.5.1. Company Overview
  • 4.6. Transgenomic, Inc.
    • 4.6.1. Company Overview
  • 4.7. Bio-Rad Laboratories, Inc.
    • 4.7.1. Company Overview
  • 4.8. Qiagen N.V.
    • 4.8.1. Company Overview

5. Genetic Testing Market Pipeline Products

6. Financial Deals Landscape

  • 6.1. Partnerships
    • 6.1.1. Genomic Vision Extends Agreement with Quest Diagnostics
    • 6.1.2. Foundation Medicine Enters into Licensing Agreement with WuXi PharmaTech
    • 6.1.3. Hibergene Diagnostics Enters into Licensing Agreement with Eiken for LAMP

7. Appendix

  • 7.1. Research Methodology
    • 7.1.1. Coverage
    • 7.1.2. Secondary Research
    • 7.1.3. Primary Research
    • 7.1.4. Company Share Analysis
    • 7.1.5. Distribution Share Analysis
  • 7.2. GlobalData Consulting
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Genetic Testing Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 2: Genetic Testing Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 3: Genetic Testing Market, China, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 4: Genetic Testing Market, China, Company Share by Revenue ($m), USD Constant, 2014
  • Table 5: Genetic Testing Market Pipeline Products
  • Table 6: Genomic Vision Extends Agreement with Quest Diagnostics
  • Table 7: Foundation Medicine Enters into Licensing Agreement with WuXi PharmaTech
  • Table 8: Hibergene Diagnostics Enters into Licensing Agreement with Eiken for LAMP

List of Figures

  • Figure 1: Genetic Testing Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 2: Genetic Testing Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 3: Genetic Testing Market, China, Company Share (%) 2014
Back to Top